Literature DB >> 8993469

On the effects of glucagon-like peptide-1 on blood glucose regulation in normal and diabetic subjects.

J J Holst1, M B Toft-Nielsen, C Orskov, M Nauck, B Willms.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8993469     DOI： 10.1111/j.1749-6632.1996.tb17549.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  7 in total

1.  A model of GLP-1 action on insulin secretion in nondiabetic subjects.

Authors:  Chiara Dalla Man; Francesco Micheletto; Airani Sathananthan; Robert A Rizza; Adrian Vella; Claudio Cobelli
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-02-23       Impact factor: 4.310

2.  Model-Based Quantification of Glucagon-Like Peptide-1-Induced Potentiation of Insulin Secretion in Response to a Mixed Meal Challenge.

Authors:  Chiara Dalla Man; Francesco Micheletto; Matheni Sathananthan; Adrian Vella; Claudio Cobelli
Journal:  Diabetes Technol Ther       Date:  2016-01       Impact factor: 6.118

Review 3.  Effects of GLP-1 on appetite and weight.

Authors:  Meera Shah; Adrian Vella
Journal:  Rev Endocr Metab Disord       Date:  2014-09       Impact factor: 6.514

Review 4.  Weight neutrality with the DPP-4 inhibitor, vildagliptin: mechanistic basis and clinical experience.

Authors:  James E Foley; Jens Jordan
Journal:  Vasc Health Risk Manag       Date:  2010-08-09

5.  The effect of dipeptidyl peptidase-4 inhibition on gastric volume, satiation and enteroendocrine secretion in type 2 diabetes: a double-blind, placebo-controlled crossover study.

Authors:  Adrian Vella; Gerlies Bock; Paula D Giesler; Duane B Burton; Denise B Serra; Monica Ligueros Saylan; Carolyn F Deacon; James E Foley; Robert A Rizza; Michael Camilleri
Journal:  Clin Endocrinol (Oxf)       Date:  2008-03-10       Impact factor: 3.478

6.  Inhibition of dipeptidyl peptidase-4: The mechanisms of action and clinical use of vildagliptin for the management of type 2 diabetes.

Authors:  Galina Smushkin; Adrian Vella
Journal:  Diabetes Metab Syndr Obes       Date:  2009-06-12       Impact factor: 3.168

7.  Benefits of liraglutide treatment in overweight and obese older individuals with prediabetes.

Authors:  Sun H Kim; Fahim Abbasi; Cindy Lamendola; Alice Liu; Danit Ariel; Patricia Schaaf; Kaylene Grove; Vanessa Tomasso; Hector Ochoa; Yeheng V Liu; Yii-Der Ida Chen; Gerald Reaven
Journal:  Diabetes Care       Date:  2013-07-08       Impact factor: 19.112
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.